Stock Market News6 months Here’s Why You Should Retain ABT Stock in Your Portfolio Now Zacks
Investors feel optimistic about Abbott’s robust strength in the Diagnostics and Nutrition business. Yet, unfavorable forex impacts are concerning.
6 months Abbott Laboratories (NYSE:ABT) Trading 0.2% Higher – Still a Buy? MarketBeat
Abbott Laboratories (NYSE:ABT) Trading Up 0.2% – Time to Buy?
7 months TCI Wealth Advisors Inc. Decreases Stock Holdings in Abbott Laboratories (NYSE:ABT) MarketBeat
TCI Wealth Advisors Inc. cut its stake in Abbott Laboratories (NYSE:ABT – Free Report) by 40.6% in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 11,393 s…
7 months Mirae Asset Global Investments Co. Ltd. Raises Stock Holdings in Abbott Laboratories (NYSE:ABT) MarketBeat
Mirae Asset Global Investments Co. Ltd. boosted its holdings in Abbott Laboratories (NYSE:ABT – Free Report) by 23.4% in the third quarter, according to its most recent Form 13F filing with the SEC. The fund owned 184,961 shares of the healthcare prod…
7 months Abbott Laboratories (NYSE:ABT) Trading Down 0.4% – Here’s What Happened MarketBeat
Abbott Laboratories (NYSE:ABT) Stock Price Down 0.4% – Here’s Why
7 months Growing Biosimilars Business Supports ABT Stock, Macro Issues Hurt Zacks
Abbott’s Diabetes Care business continues to benefit from the growing sales of its flagship, sensor-based continuous glucose monitoring system, FreeStyle Libre.
7 months Bank Pictet & Cie Europe AG Increases Stake in Abbott Laboratories (NYSE:ABT) MarketBeat
Bank Pictet & Cie Europe AG grew its position in Abbott Laboratories (NYSE:ABT – Free Report) by 4.6% during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional inves…
7 months Abbott Laboratories (NYSE:ABT) Trading Down 0.2% – What’s Next? MarketBeat
Abbott Laboratories (NYSE:ABT) Trading Down 0.2% – Here’s Why
7 months Mattern Wealth Management LLC Cuts Stake in Abbott Laboratories (NYSE:ABT) MarketBeat
Mattern Wealth Management LLC decreased its position in Abbott Laboratories (NYSE:ABT – Free Report) by 41.5% during the third quarter, according to the company in its most recent disclosure with the SEC. The firm owned 20,862 shares of the healthcare…
7 months Abbott Laboratories (NYSE:ABT) Trading Down 1.7% – Here’s Why MarketBeat
Abbott Laboratories (NYSE:ABT) Shares Down 1.7% – Time to Sell?
7 months MDT vs. ABT: Which Stock Is the Better Value Option? Zacks
MDT vs. ABT: Which Stock Is the Better Value Option?
7 months Penn Davis Mcfarland Inc. Makes New $3.62 Million Investment in Abbott Laboratories (NYSE:ABT) MarketBeat
Penn Davis Mcfarland Inc. acquired a new position in Abbott Laboratories (NYSE:ABT – Free Report) during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund acquire…
7 months Market Digest: ABT, KEY, MAN, NFLX, PPG, BMI Yahoo Finance
7 months Abbott Laboratories: Long-Term Optimism, Short-Term Overvaluation Seeking Alpha
7 months Creative Planning Raises Stock Position in Abbott Laboratories (NYSE:ABT) MarketBeat
Creative Planning lifted its position in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 6.7% in the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 808,863 shares of the h…
The Stock Market News
The Stock Market News is a financial news aggregator for traders and investors that proposes to you the latest breaking news headlines on global financial markets, economy and business. Live qoute and chart technical analysis, opinion, price forecast on current stock market, currencies (Forex), cryptocurrency, commodities futures, ETFs, funds, bonds and more. Disclaimer: by using any material of this website, you acknowledge and agree that TheStockMarketNews.com is not responsible for the content, actions or any legal issues arising from third-party websites; materials of this website are not financial advice or call to actions. Trading and investing in financial instruments involve high risks including the risk of investment loss.